Abstract

The tenascins are a highly conserved family of large oligomeric glycoproteins found in the extracellular matrix (ECM) 1 of vertebrate organisms. Two decades ago, the molecule now known as tenascin-C was among the first proteins shown to have an adhesion modulatory role antagonizing cell attachment to fibronectin (1). Cells that normally demonstrate a stationary phenotype on the fibronectin-containing matrix by spreading out and forming cortical actin stress fibers (Fig. 1A) will show morphological changes when tenascin-C is included in the matrix by extending membrane protrusions and exhibiting decreased stress fiber formation (Fig. 1B), characteristics more typical of a migratory phenotype (2). The presence of ECM proteins such as tenascins during developmental and pathological states is now well recognized if still not well understood. Although each type has a distinctive expression pattern, the tenascins share the characteristic of having tightly regulated expression during development and throughout an organism's life. Tenascins also share the characteristic of modulating cell-matrix interactions and mediating a state of matrix attachment that promotes motility while also influencing other cell functions. As such, this protein family has important functions not only during development but also during pathological states in the adult such as tissue injury and tumorigenesis where remodeling processes are prominent. Reviews in recent years have covered pertinent aspects of tenascin biology including domain structure, modulation of cell functions, in vivo null deletion phenotypes, and contributions to human pathology (3-10). This minireview will provide a concise summary of information from these reviews, which the reader is encouraged to refer to for greater detail, and will also discuss a few of the more recent developments in the field.

Highlights

  • Repeats, epidermal growth factor (EGF)-like repeats, fibronectin type III domain repeats, and a carboxyl-terminal fibrinogen-like globular domain

  • Isoform variants produced through alternative splicing within the fibronectin type III repeats have been described across the family; to date, only tenascin-C has shown splice variants being expressed in significant numbers and diversity [5, 7]

  • It is believed that the different regions of tenascin-C have distinct actions and functions, it is probable that the overall effects of tenascin-C on cells and their interactions with the extracellular matrix (ECM) require the concerted action of multiple domains [14]

Read more

Summary

Introduction

Repeats, epidermal growth factor (EGF)-like repeats, fibronectin type III domain repeats, and a carboxyl-terminal fibrinogen-like globular domain. Each protein member is associated with typical variations among different species in the number and nature of EGF-like and fibronectin type III repeats. Isoform variants produced through alternative splicing within the fibronectin type III repeats have been described across the family; to date, only tenascin-C has shown splice variants being expressed in significant numbers and diversity [5, 7].

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call